Company News: ISA Pharmaceuticals´ Chief Scientific Officer Prof. Cornelis Melief Receives ESMO Immuno-Oncology Award 2018
ISA Pharmaceuticals B.V., a clinical-stage immuno-oncology company, today announced that its Chief Scientific Officer Prof. Cornelis Melief has been selected by the European Society for Medical Oncology (ESMO) to receive the 2018 ESMO Immuno-Oncology Award in recognition of his life’s work in studying the interactions of the immune system with cancer. Read more…
Company News: Cardior strengthens patent portfolio of miRNAs for the diagnosis and therapy of heart and kidney diseases
— Key patents acquired from Bayerische Patentallianz
Cardior Pharmaceuticals GmbH, a company focused on the development of noncoding RNA (ncRNA) therapeutics for patients with myocardial infarction and heart failure, today announced it has acquired a portfolio of four microRNA (miRNA) patents from Bayerische Patentallianz GmbH (BayPAT).
Company News: Heraeus Medical facilitates hospital-patient interaction with new digital solution
— HeraeusCare® digitizes pre- and post-operative patient care in orthopedic surgery
— Improved medical outcomes and significant cost savings
In order to streamline hospital-patient interactions in orthopedic surgery, Heraeus Medical provides a novel web-based digital solution. It includes a dashboard for hospitals and a mobile application for patients. The solution called HeraeusCare® will be introduced at this year´s German Congress of Orthopaedics and Traumatology (DKOU) in Berlin, Germany, from October 23 to 26, 2018. An onsite demo of the solution will be shown at Heraeus Medical´s conference booth (Hall 4.2, booth no. 74).
